Obstructive sleep apnea (OSA) is a common sleep disorder affecting high proportion of the population. This disorder is associated with an increase in the oxidative stress and cardiovascular disease. Paraoxonase (PON) is a lipolactonase enzyme removing toxic lipids and decreasing lipoprotein oxidation. The present study was conducted to reassess possible alternation of PON activities in OSA patients. Studies measured PON activities in OSA were searched in PubMed, Scopus, EMBASE, Web of Science databases, and Cochrane Library from January 1990 to February 2019. Screening of the studies was performed by two authors independently according to title, abstract, and full text. Quality of studies was assessed by Newcastle-Ottawa Quality Assessment Scale, and random-effect model was used for evaluating the effect of OSA on PON activities. A total of 97 records were found in searching, 39 duplicated records were removed, and 5 studies for PON activity and 2 studies for aryl-esterase (ARE) activity were included in the meta-analysis. Pooled analysis showed no significant difference in terms of PON activity between OSA and control groups (p = 0.434). Similarly, ARE demonstrated no significant difference between OSA and control groups (p = 0.515). Subgroup meta-analysis according to age, BMI, AHI, and diagnosis criteria demonstrated no significant difference between two groups. The results of this study indicated no association between OSA and PON activities as an antioxidant enzyme. However, a relatively low number of studies limited us to conclude a definite conclusion; therefore, more studies are needed in this regard.
Introduction
Obstructive sleep apnea (OSA) is the most prevalent sleep disorder affecting 3-7% of general population worldwide [1, 2] . OSA is characterized by recurrent apnea or hypopnea leading to frequent episodes of arousal and intermittent hypoxia [3, 4] . On the other hand, OSA is an independent risk factor for development of atherosclerosis-based cardiovascular disease (ASCVD) [5] . Several mechanisms have been proposed for mechanistic links between OSA and ASCVD, such as inflammation, oxidative stress, and endothelial dysfunction [5] .
Intermittent hypoxia and re-oxygenation during episodes of apnea and breathing resume leads to reactive oxygen species (ROS) formation from mitochondria [6] . ROS is the main precursor of oxidative damages to biomolecules such as lipids and lipoproteins [7] . Indeed oxidative damage to these biomolecules is a key factor in the pathogenesis of atherosclerosis as the main mechanism of ASCVD [8] . Oxidized lipoproteins and lipids in arterial walls initiate recruitment of immune cells and uptake of oxidized LDL (Ox-LDL) by macrophages constituting the foam cell in intima of arterial walls [9] . The body has antioxidant system protecting it from oxidative damages. It is composed of several enzymes and biomolecules such as glutathione and paraoxonase [10] .
Paraoxonase protects lipids and lipoproteins from oxidation, and is present in the membrane of cells [11] . It also is bound to high density lipoprotein in the circulation [11] . Lactonase activity is the primary activity of PON. Furthermore, PON degrades lipid peroxides in lipoproteins; it also protects lipoproteins from oxidation [12] . In addition, it has esterase activity degrading the nerve agents and organophosphates [12] .
Studies have shown protective roles for PON against ASCVD; these roles might result from protective activity of PON against lipoprotein oxidation and removing lipid peroxides as risk factors of atherosclerosis [13] .
Several studies reported perturbation in oxidative and antioxidant balance in patients with OSA [14, 15] . There are several reports on PON activities in OSA patients; however, the results are inconsistent [16, 17] . Therefore, the present study aimed to reassess the published studies on PON activity in OSA patients compared with controls.
Methods

Search
Studies were searched in PubMed, Scopus, EMBASE, Web of Science databases, and Cochrane Library. PICO format was used for formulating the study question. The study population included the patients with OSA, and PON activities were considered as risk factor. Healthy controls were considered as comparison group, and risk of OSA was the outcome. The following key words were used for the study question: Paraoxonase or Paraoxonase 1 or Paraoxonase-1 or PON or PON 1 or PON-1 and Sleep Apnea Syndrome or Sleep Apnea or Obstructive sleep apnea or OSA or OSAS. Search was carried out from January 1990 to February 2019.
There was no systematic review about paraoxonase activity in sleep apnea patients in the Cochrane database. Furthermore, reference checking was performed on the eligible studies.
Inclusion and Exclusion Criteria
Inclusion criteria were as follow: 1) Performing PSG for all subjects 2) diagnosis of OSA and controls according to apnea hypopnea index (AHI) ≥ 5 for patients, 3) having the age over 18 years old, 4) measurement of serum or plasma activity of 
Study Selection
Following the search, all records were exported to End note program. Two authors performed study selection independently. After removing the duplicated papers, abstract of the remained papers were checked, and unrelated papers were removed. In the next step, full text of the remained papers was checked, and unrelated papers were removed.
Risk of Bias Assessment
Quality of the included studies was evaluated by two authors independently using Newcastle-Ottawa Quality Assessment Scale (NOS). Using this tool quality of selection, comparability, exposure, and outcome of each study were determined with a maximum score of 9 points. Accordingly, studies were divided into two categories: (1) high quality (scored 5 to 9) and (2) low quality (scored 0 to 4). Disagreements were resolved through discussion.
Data Extraction
A form was used for data extraction including the information on (1) publication year, (2) sample size, (3) age, (4) BMI, (5) PON activity, (6) ARE activity, and (7) assay approach for paraoxonase activity.
Statistical Analysis
PON and ARE activity were described by mean ± SD in the groups. Standardized mean difference (SMD) was the main summary measure to evaluate difference between OSA patients and controls. Der Simoniane Laird random-effects model was applied to measure the SMDs. I 2 used to assess the heterogeneity. Subgroup analysis was performed by at least two studies. Subgroups were defined based on the age, BMI, AHI, and method for measuring PON or ARE activities. All analyses were conducted using STATA software (version [22] 2 0 1 2 n r n r n r n r n r n r n r n r n r n r TG triglycerides, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, CG control group, PG patients group, EDS excessive daytime sleepiness, nr not reported * Comorbidities include cardiovascular diseases, diabetes, neurologic diseases, liver diseases, kidney diseases, cancer, and excessive daytime sleepiness.
14.2). Publication bias was evaluated using Begg's and
Egger's tests. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) guideline was followed to report the study [18] .
Results
As indicated in Fig. 1 , a total of 97 records were found in searching. A total of 39 duplicated records were removed, 40 records were removed for irrelevant title or abstract, and 18 records remained for review. Six papers had different diagnosis criteria from the criteria set for inclusion, 3 studies did not meet the diagnosis criteria, and 2 papers had inadequate data for meta-analysis.
Characteristics of Eligible Studies
A total of 5 studies including 131 OSA patients and 93 controls were included in the meta-analysis [16, [19] [20] [21] [22] . All studies had reported PON activity, while two studies had reported ARE activity, and no study had reported LAC activity. Furthermore, two studies had subgroups, and the study by [20] . Basic characteristics of studies are shown in Table 1 . The basic data included first author name, year of publication, sample size, mean of AHI, age, BMI, PON activity, and ARE activity. In addition, data on comorbidities and lipid profile of eligible studies are given in Table 2 .
Pooled Analysis
The heterogeneity test showed relatively high heterogeneity (I 2 = 83.5%, p < 0.001). Regarding this result, random effect model was performed to combine effect size. Meta-analysis for PON activity demonstrated no significant difference between OSA patients and controls (Fig. 2) . Similarly, ARE showed no significant difference between patients and controls ( Fig. 3 ).
Subgroup Analysis for PON Activity
The results of subgroup analysis for PON activity are given in Table 3 . Meta-analysis using studies/study groups in each of the studies showed no significant difference in terms of PON activity between OSA patients and controls, as AHI > 5 was set for OSA diagnosis. Moreover, studies were categorized according to AHI. The results demonstrated no significant difference in both subgroups between OSA patients and controls. Likely, subgroup analysis according to BMI and age showed no significant difference. Furthermore, a study that had used semi automat method for measuring PON activity reported no significant difference between OSA patients and controls. Other studies that had used p-Nitrophenol for PON activity assay indicated no significant difference between the groups. 
Subgroup for ARE Activity
Similar subgroup analysis was performed for ARE activity. All studies considered AHI > 5 for diagnosis of OSA, and there was no significant difference between OSA patients and controls. Two studies that had case group with a mean AHI of ≥ 30 showed no significant difference. Furthermore, a study that had a mean AHI of < 30 reported higher ARE activity in OSA patients. In addition, 2 studies that had a mean age of ≥ 45 indicated no significant difference, and a study that had a mean age of < 45 reported higher ARE activity in the patients (Table 4 ).
Publication Bias
Publication bias was tested for PON activity using the Begg's and Egger's tests, and low risk of publication bias was found (p = 0.902 and p = 0.867, respectively). Similar tests were used for ARE activity, and the results showed low risk of publication bias (the p values were obtained as 0.296 and 0.094, respectively, for the Begg' and Egger's tests). In addition, 3 studies had low quality, and 2 studies had high quality.
Discussion
Studies have reported conflicting reports on PON activities in patients with OSA [16, [19] [20] [21] [22] and the present study was aimed to reassess studies on PON activities in serum/plasma of OSA patients compared with controls. The results indicated no significant difference in PON and ARE activities between OSA patients and controls. OSA is associated with perturbation of oxidative and antioxidant balance. High oxidative stress in OSA has been reported to result from the elevated production of ROS by leukocytes obtained from OSA patients [23] .
PON is an antioxidant enzyme with cardioprotective activities such as lipids detoxification and removing oxidized lipid from lipoproteins [11, 12] . Regarding the increased ROS production and increased oxidative stress in OSA patients, PON activity is expected to increase in these patients to reduce the damages in this condition. While the lack of change between the OSA patients and controls could be a possible cause for an increase in the oxidative damage in OSA patients.
With regard to the heterogeneity of the studies, subgroup analysis was performed using possible covariates.
Oxidative stress was found to have positive association with AHI [15, 24] ; however, subgroup analysis according to AHI showed no significant difference in PON activity. In addition, subgroup analysis according to age indicated no significant difference, while PON activity has been reported as an age-dependent factor [11] . Obesity is a factor that could influence on PON activity [25] ; however, PON activity illustrated no significant difference with respect to BMI categories.
There were several limitations in the present study including a relatively low number of eligible studies and subjects that limited us to conclude a definite conclusion; thus, more studies are needed on PON activity in OSA patients. In addition, high level of heterogeneity was found between the studies, but we failed to find out the source of heterogeneity because of the limited number of studies.
Conclusion
The results of the study showed that PON activities had no significant difference between OSA patients and controls. With regard to antioxidant activity of PON, possibly a compensatory increase has not been occurred in PON activity in response to the increased oxidative stress in OSA patients.
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